<DOC>
	<DOCNO>NCT02165839</DOCNO>
	<brief_summary>PRIMARY OBJECTIVE ( S ) : The purpose study test efficacy brief behavioral therapy versus control condition account time attention ( nutrition education ) treatment insomnia human . SECONDARY OBJECTIVE ( S ) : To assess impact different biomarkers sleep disruption patient report outcome</brief_summary>
	<brief_title>Brief Behavioral Intervention Insomnia During Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>Be female diagnosis Breast Cancer ( Stage IIIIA ) . Be schedule planned cancer treatment ( e.g . chemotherapy biologics herceptin ) . Have least 6 week cancer treatment ( e.g . chemotherapy biologics herceptin ) remain . Be least 21 year age . Be able understand write spoken English . Report sleep disturbance 8 great ISI , report insomnia begin get bad diagnosis cancer treatment chemotherapy ( exclude preexisting , chronic insomnia ) . Have Karnofsky score &gt; = 70 ensure patient able participate intervention assessment . Exclusion Criteria Have unstable selfreported medical psychiatric illness ( Axis I current within last 5 year ) . Be currently pregnant nursing ( patient monitor pregnancy chemotherapy pregnant woman first trimester administer chemotherapy . Therefore , pregnancy status woman know prior entrance study ) . Have history substance abuse meet criterion current alcohol abuse dependence Have selfreported history sleep apnea restless leg syndrome ( RLS ) Selfreport medical record unstable comorbid medical psychiatric condition would make unsafe impossible adhere study protocol Are unable unwilling discontinue anxiolytic within 4 hour education session Have irregular heartbeat arrhythmia ( selfreported medical record )</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>